219 SorianoF
But research shows it might shorten your cold by a day or so, and it might make your symptoms a little milder
Summary: Retatrutide is an investigational triple receptor agonist targeting GLP-1, GIP, and glucagon receptors, currently in Phase 3 trials for obesity and type 2 diabetes but not yet approved by the MHRA, EMA, or FDA
Nielsen R, Jorsal A, Iversen P, Tolbod LP, Bouchelouche K, Srensen J, Harms HJ, Flyvbjerg A, Tarnow L, Kistorp C, et al
Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive type 2 Diabetes Management Algorithm2017 Executive Summary
Ultimately, I was able to get on my fiances insurance, and now I finally have access to Wegovy